Evidence map›Paper›PMID 25378487›Full record

ArticleJournal of virology2015

A conserved regulatory module at the C terminus of the papillomavirus E1 helicase domain controls E1 helicase assembly.

Stephen Schuck, Arne Stenlund

Abstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Mechanisms of hexameric helicases.Critical reviews in biochemistry and molecular biology · 2021
    Review
  2. Article
  3. Article
  4. Article
  5. Papillomaviruses: a systematic review.Genetics and molecular biology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stephen SchuckCold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
Arne StenlundCold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA stenlund@cshl.edu.

Funding

Biochemical analysis of papillomavirus replicationR01AI072345 · NIAID · COLD SPRING HARBOR LABORATORY · PI STENLUND, ARNE · 2008 to 2011
$1.5M
NIAID NIH HHS R01 AI072345
6 · The paper itself

Abstract

unlabelledViruses frequently combine multiple activities into one polypeptide to conserve coding capacity. This strategy creates regulatory challenges to ascertain that the combined activities are compatible and do not interfere with each other. The papillomavirus E1 protein, as many other helicases, has the intrinsic ability to form hexamers and double hexamers (DH) that serve as the replicative DNA helicase. However, E1 also has the more unusual ability to generate local melting by forming a double trimer (DT) complex that can untwist the double-stranded origin of DNA replication (ori) DNA in preparation for DH formation. Here we describe a switching mechanism that allows the papillomavirus E1 protein to form these two different kinds of oligomers and to transition between them. We show that a conserved regulatory module attached to the E1 helicase domain blocks hexamer and DH formation and promotes DT formation. In the presence of the appropriate trigger, the inhibitory effect of the regulatory module is relieved and the transition to DH formation can occur. IMPORTANCE: This study provides a mechanistic understanding into how a multifunctional viral polypeptide can provide different, seemingly incompatible activities. A conserved regulatory sequence module attached to the AAA+ helicase domain in the papillomavirus E1 protein allows the formation of different oligomers with different biochemical activities.

Indexed as

Gene Expression Regulation, ViralProtein MultimerizationConserved SequenceDNA HelicasesPapillomaviridaeProtein Structure, TertiaryDNA Helicases

Identifiers

PMID25378487
PMCPMC4300631

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.